# Doxycycline in Cutaneous Schwannoma (NF2)

> **NCT05521048** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts Eye and Ear Infirmary** · enrollment: 19 (estimated)

## Conditions studied

- Neurofibromatosis Type 2

## Interventions

- **DRUG:** Doxycycline Injection [Doxy]

## Key facts

- **NCT ID:** NCT05521048
- **Lead sponsor:** Massachusetts Eye and Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-09-19
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-12
- **Target enrollment:** 19 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05521048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05521048, "Doxycycline in Cutaneous Schwannoma (NF2)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05521048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*